The 3S-AF scheme, rather than the 4S-AF scheme, predicts progression in patients with paroxysmal atrial fibrillation: data from RACE V study

Back

EHRA Premium Access

The 3S-AF scheme, rather than the 4S-AF scheme, predicts progression in patients with paroxysmal atrial fibrillation: data from RACE V study

Session: New on atrial fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor V. Artola (Utrecht, NL)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Doctor Vicente Artola

University Medical Center Utrecht, Utrecht (Netherlands (The))

0 follower

4 more presentations in this session

Evolving changes of outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study.

Speaker: Professor L. Fauchier (Tours, FR)

Incident arrhythmias, heart failure and cardiovascular outcomes with SGLT-2 inhibitor use in diabetic patients: Insights from a global federated electronic medical record database

Speaker: Doctor A. Fawzy (Liverpool, GB)

Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in the general population

Speaker: Doctor A. Fawzy (Liverpool, GB)

Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project

Speaker: Doctor A. Fawzy (Liverpool, GB)

Access the full session

New on atrial fibrillation

Speakers: Doctor V. Artola, Professor L. Fauchier, Doctor A. Fawzy, Doctor A. Fawzy, Doctor A. Fawzy

Access

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources